$255.16 general Payment -- Johnson & Johnson to Dr. Scott Collins

Dermatologist Scott Collins Receives $255.16 General Payment from Johnson & Johnson

This page provides a detailed analysis of a $255.16 general payment from Johnson & Johnson to Dr. Scott Collins. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$255.16
Payment Typegeneral
Payment NatureCompensation for services other than consulting
Pharmaceutical CompanyJohnson & Johnson
PhysicianDr. Scott Collins
NPI Number1760570425
Physician SpecialtyDermatology
LocationCity, SC
Date of Payment2026-02-10
Conflict AssessmentLow -- Routine

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Johnson & Johnson made a $255.16 general payment to Scott Collins, a Dermatology specialist in City, SC. The payment of $255.16 to Dr. Scott Collins from Johnson & Johnson on February 10, 2026, falls under 'Compensation for services other than consulting'. This payment is categorized as 'general' and is relatively small in amount. Dr. Collins' specialty is Dermatology, and the payment was made in South Carolina.

Patient Guidance: What This Payment Means for You

This payment represents compensation for services other than consulting, and its details are publicly available through the CMS Open Payments program. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

For a dermatologist, a payment of $255.16 for services other than consulting is generally considered a low-value transaction compared to larger consulting or speaking fees.

Regulatory Context: Sunshine Act Requirements

This transaction is reported under the Physician Payments Sunshine Act, part of the Affordable Care Act, requiring disclosure of payments made by manufacturers to physicians and teaching hospitals.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding general Payments

general payments are one of several categories of financial transfers from pharmaceutical and medical device companies to physicians that must be reported under the Sunshine Act. Understanding the type and context of a payment is important for evaluating its significance. Not all payments are equal -- a research grant has very different implications than a promotional speaking fee.

Frequently Asked Questions About This Payment

What was this $255.16 payment for?

This was a general payment of $255.16 from Johnson & Johnson to Scott Collins, categorized as "Compensation for services other than consulting". The payment was reported under the Sunshine Act (CMS Open Payments).

Does Scott Collins accept pharmaceutical money?

Yes, Scott Collins received this $255.16 payment from Johnson & Johnson. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Scott Collins's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this general payment?

A general payment of $255.16 should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Dermatology?

To compare this payment against Dermatology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Dermatology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Scott Collins's relationship with Johnson & Johnson?

The payment amount is below the typical threshold for significant financial relationships. This $255.16 general payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Dermatology?

The nature of the payment suggests a service rendered, not direct consulting.

What should patients do after learning about this payment?

This payment represents compensation for services other than consulting, and its details are publicly available through the CMS Open Payments program.

What else should I know about this general payment?

The date of payment is in the future, indicating a potential pre-scheduled transaction.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.